Tested Applications
| Positive WB detected in | MCF-7 cells, HEK-293 cells, mouse brain tissue |
| Positive IHC detected in | mouse brain tissue, human colon tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:2000 |
| Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
25335-1-AP targets CHD3 in WB, IHC, ELISA applications and shows reactivity with human, mouse samples.
| Tested Reactivity | human, mouse |
| Cited Reactivity | human |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
Peptide Predict reactive species |
| Full Name | chromodomain helicase DNA binding protein 3 |
| Calculated Molecular Weight | 227 kDa |
| Observed Molecular Weight | 240-250 kDa |
| GenBank Accession Number | NM_005852 |
| Gene Symbol | CHD3 |
| Gene ID (NCBI) | 1107 |
| RRID | AB_2880033 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q12873 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
CHD3, also named as Mi2 ALPHA or Zinc finger helicase, is a 2000 amino acid protein, which contains one helicase C-terminal domain, one helicase ATP-binding domain, and two chromo domain. CHD3 localizes in the nucleus and cytoplasm. CHD3 is widely expressed. CHD3 is a component of the histone deacetylase NuRD complex, which participates in the remodeling of chromatin by deacetylating histones. CHD3 is required for anchoring centrosomal pericentric in both interphase and mitosis.
Protocols
| Product Specific Protocols | |
|---|---|
| IHC protocol for CHD3 antibody 25335-1-AP | Download protocol |
| WB protocol for CHD3 antibody 25335-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The CHD3 polyclonal antibody (Cat# 25335-1-AP) has 3 citations published in Molecular Cell, Nucleic Acids Research, and PNAS. The cited studies focus on chromatin remodeling via the NuRD complex, epigenome reprogramming, and cancer biology—specifically breast cancer development and prostate cancer immune evasion through the STAT1–MHC-I axis. All citations used Western blot as the application in human samples.
| Species | Application | Title |
|---|---|---|
Mol Cell NuRD-enabled CTCF-TET crosstalk orchestrates epigenome reprogramming and genome architecture. | ||
Nucleic Acids Res CARM1 hypermethylates the NuRD chromatin remodeling complex to promote cell cycle gene expression and breast cancer development | ||
Proc Natl Acad Sci U S A ZNF263-NuRD-mediated repression of STAT1 curtails MHC-I antigen presentation and IFN-γ efficacy in prostate cancer |























